http://surgerybook.net/
neuromuscular and mild GI symptoms. Cardiac and renal complications typically occur later in disease
progression.
Treatment. Serum calcium concentration >14 mg/dL requires prompt treatment. If combined with
hyperphosphatemia, this situation is even more concerning due to the potential for metastatic
calcification. Initial treatment should include aggressive hydration with 0.9% normal saline with 20
mEq/L potassium with a goal of hydration to promote a urine output greater than 200 mL/hr. Once the
patient is adequately hydrated a trial of furosemide can be performed as long as a positive fluid balance
is maintained and potassium and magnesium are adequately replaced. Other adjuncts include calcitonin
(especially for inhibition of bone resorption), bisphosphonates (especially to treat malignancy), and in
patients with renal failure the use of low-calcium dialysate. Patients with hematologic malignancies and
granulomatous disease can be considered for treatment with steroids. Lastly, for those with
hyperparathyroidism, parathyroidectomy of some form is clearly indicated, with operation type
dependent upon whether the etiology is adenoma or hyperplasia. In medically refractory secondary or
tertiary hyperparathyroidism, total parathyroidectomy with parathyroid autotransplantation or sub-total
parathyroidectomy should be considered.46
Hypocalcemia
There are many causes of hypocalcemia (Table 11-15). Other factors can affect the serum calcium level
as mentioned previously, namely pH and albumin. In critically ill patients the incidence of hypocalcemia
can be up to 85%. From a surgical perspective the most common causes are postsurgical, including
hungry bone syndrome and loss of calcium from circulation.
Table 11-14 Signs and Symptoms of Hypercalcemia
Postsurgical hypocalcemia can occur in any neck surgery, although the incidence is higher with
parathyroidectomy. In non-neck surgery hypocalcemia can occur because of hypoalbuminemia; this does
not affect ionized calcium levels. Other postsurgical causes of hypocalcemia include atrophy of the
remaining parathyroid glands (i.e., after removal of a large parathyroid adenoma), venous congestion,
devascularization or hungry bone syndrome. Transient hypoparathyroidism is seen in up to 20% of
thyroid cancer surgery; this is permanent in 1% or less of cases.
Other surgery-related etiologies include pancreatitis, small bowel fistula, renal failure, massive
transfusion of blood, and severe hypomagnesemia. Pancreatitis-induced hypocalcemia occurs due to
calcium precipitation in peripancreatic tissue. Small bowel fistula can lead to hypocalcemia by loss of
calcium-rich effluent and vitamin D deficiency from malnutrition. Renal failure hypocalcemia is due to
deficiency in 1,25-dihydroxyvitamin D and hyperphosphatemia. Massive transfusion hypocalcemia does
not affect total calcium but decreases ionized calcium as a result of citrate binding to ionized calcium.
Symptoms typically do not occur until calcium levels are below 8 mg/dL. Chronic symptoms include
cataracts, dental changes, and extrapyramidal disorders. Symptoms of acute hypocalcemia are tetany,
papilledema, and seizures. Tetany is defined as repetitive discharges after a single stimulus. Tetany
usually does not occur until ionized calcium is less than 4.3 mg/dL or serum total calcium is less than
7.0 mg/dL. Alkalosis also plays a strong role in the development of tetany, even beyond its association
with hypocalcemia, as tetany is rarely seen in renal failure patients despite low calcium levels. This is
likely due to the protective effect of concurrent metabolic acidosis. The earliest symptoms of
hypocalcemia are perioral and acral paresthesias. Motor symptoms such as Trousseau sign (induction of
carpopedal spasm by inflation of sphygmomanometer above systolic pressure for 3 minutes) and
Chvostek sign (tap facial nerve and ipsilateral facial muscles twitch) occur later. Of note, Chvostek sign is
seen in up to 10% of normal patients. The last findings to occur are cardiac, in the form of ST segment
358
http://surgerybook.net/
prolongation (Table 11-16).44
Table 11-13 Differential Diagnosis of Hypercalcemia
Table 11-15 Causes of Hypocalcemia
Asymptomatic hypocalcemia needs no treatment as it is most commonly attributed to
hypoalbuminemia with normal ionized calcium. Symptomatic hypocalcemia is best treated with
intravenous infusion of calcium gluconate or calcium chloride. Calcium chloride is faster acting as it
does not require hepatic metabolism to dissociate into an active form, hence is usually the drug of
choice if severely symptomatic. A study during the anhepatic stage of liver transplantation found
equally rapid increase in calcium after administration of calcium chloride and gluconate.47 Calcium
chloride carries a higher risk of irritation of veins and tissue damage should extravasation occur; hence
calcium gluconate should be the drug of choice except in emergent situations. In order to minimize
caustic damage to veins, any form of calcium should be administered at a rate not to exceed 1.5
mEq/min. If prolonged calcium replacement is needed it is recommended to check vitamin D levels and
replace any deficiency with calcitriol, in addition to giving an oral form of calcium such as calcium
carbonate, calcium citrate, or calcium lactate.
Table 11-16 Clinical Manifestations of Hypocalcemia
Magnesium
359
http://surgerybook.net/
Half of the total body magnesium is confined to bone. Most of the remaining magnesium is
intracellular, with less than 1% of total body magnesium found extracellular. Magnesium is primarily
absorbed in the small intestine and is influenced by 1,25-dihydroxyvitamin D3. The other source of
magnesium is bone.
Hypermagnesemia
Outside of renal failure, hypermagnesemia is rare, as the kidneys have a strong ability to excrete large
amounts of magnesium. Instances do occur with severe burns, crush injuries, or other causes of
rhabdomyolysis but usually in the setting of renal insufficiency. Symptoms of hypermagnesemia include
loss of deep tendon reflexes at levels greater than 8 mg/dL. Once levels are greater than 12 mg/dL
paralysis can occur. Cardiac arrest can occur if levels exceed 18 mg/dL. The mainstay of treatment is
intravenous calcium to antagonize the effect of magnesium, volume expansion or loop diuretic
depending on volume status, correction of acid–base disturbances and if needed, hemodialysis.
Hypomagnesemia
Kidneys are also able to conserve magnesium quite well with about 40% reabsorption in the proximal
tubule. Most instances of hypomagnesemia occur with chronic malnutrition, prolonged intravenous fluid
replacement without magnesium, and loop diuretics. Other causes include pancreatitis and diabetic
ketoacidosis (DKA). Magnesium functions as a cofactor for many neuromuscular functions, thus
deficiency can lead to muscle fasciculation or tetany. The treatment depends on the severity, which
includes taking into account symptoms and magnesium level. For instance, if serum magnesium level is
less than 1 mEq/L or if the patient is hemodynamically unstable or is in a torsade de pointes arrhythmia
then immediate infusion of intravenous magnesium sulfate is indicated. The maximum recommended
rate would be 150 mg/min excluding the above emergent situations where it can be given as IV push or
over 5 minutes for torsade de pointes. If the patient has chronic or mild hypomagnesemia, oral doses of
magnesium should be used, with options including magnesium oxide, magnesium chloride, and
magnesium hydroxide (milk of magnesia) depending on side-effect profiles. It should be noted that
doses greater than 80 mEq/day can become cathartic.
ACID–BASE
An acid is defined as a chemical that can donate a hydrogen ion (H+), for example, HCl and H2CO3
. A
base is a chemical that can accept an H+, for example, OH− and HCO3−. Ampholytes are both acids and
bases; an example is H2PO4−, which can donate an H+ to become HPO4
2− but can also accept H+ to
become H3PO4
. Bases are commonly anions, but neutral substances can also function as bases (e.g.,
ammonia and creatinine). Some chemicals do not fit the classic definition of an acid, although they
retain acidic properties when dissociated in water. For example, when CaCl2
is dissolved in water, the
Ca2+ accepts OH− to form Ca(OH)2
.
The concentration of hydrogen ions [H+] determines the acidity of a solution. The pH is the negative
logarithm of [H+] expressed in moles per liter (mol/L). The concentration of H+ in biologic systems is
in the range of nanomoles (10−9 mol) per liter (nmol/L). The degree to which an acid dissociates
determines its strength.
Table 11-17 HCO3
− and PCO2 Derangements in Primary and Secondary Acid–Base
Disturbances
The Henderson–Hasselbalch equation describes pH as a measure of acidity in a biologic system.
pH = pKa + log10
([A-]/[HA])
pKa = Negative log of the acid dissociation constant
360
http://surgerybook.net/
A- = Conjugate base
HA = Acid–base pair
Buffer Systems
Buffers are chemicals in solution that tend to minimize changes in pH that would otherwise occur after
the addition of acid or alkali. For instance, if a strong base is added to a weak acid, the base is
neutralized:
NaOH - H2CO3 → NaHCO3 + H2O
One type of buffer is a mixture of a weak acid and its salt. The presence of such buffer systems in the
body is crucial in minimizing changes in pH, which can be deleterious to cell function.
The principal intracellular buffers are organic phosphates, bicarbonate, and peptides. In addition,
hemoglobin functions as a significant buffer in red blood cells. The major extracellular buffer is
bicarbonate. An approximation of the total body buffer capacity is 15 mEq/kg. More than half of the
total body alkaline buffer content is located outside the ECF and may in large part reside in bone.50 The
buffer pair carbonic acid/bicarbonate (H2CO3/HCO3−) is the primary buffer system of the body.
From a chemical point of view, the ideal buffer should have a pKa that allows normal physiologic pH.
The H2CO3/HCO3− buffer system has a pKa of only 6.1, which is not the normal body pH. That said,
this buffer system is efficient because of the presence of large amounts of bicarbonate, the conversion of
its acid H2CO3
to CO2
that is rapidly excreted through the lungs, and an inexhaustible supply of CO2
from metabolism.
Acid–Base Disturbances
9 There are four primary acid–base disturbances, each of which are related to changes in either
[HCO3−] or PCO2
. These are categorized as metabolic and/or respiratory (Table 11-17). A metabolic
acidosis is a decrease in pH as a result of a relative decrease in [HCO3−], whereas a metabolic alkalosis
is an increase in pH caused by a relative increase in [HCO3−]. A respiratory acidosis is a decrease in pH
secondary to a relative increase in PCO2
, and a respiratory alkalosis is an increase in pH caused by a
relative decrease in PCO2
. In each of these disorders, compensatory changes occur to minimize changes
in the relative ratio of [HCO3−] to PCO2 and thereby blunt the effect of the primary disturbance on
pH.48,49
Metabolic Acidosis
Anion Gap
The difference in the measured serum cations and anions yields the anion gap. This can be utilized to
identify the etiology of a metabolic acidosis. The most common equation used in practice is as follows:
Anion gap = [Na+] - ([Cl
-] + [HCO3])
The normal value of serum anion gap is approximately 3 to 10; however, each laboratory should
establish its own normal. If one includes potassium in the equation then the normal value should be
increased by about 4 mEq/L. The differential for an elevated anion gap acidosis includes: lactic acidosis,
salicylate poisoning, acute or chronic kidney disease, chronic acetaminophen ingestion, ketoacidosis
(i.e., diabetic), and acute or chronic kidney disease. A common mnemonic used to address etiologies is
the acronym: MUDPILES: methanol, uremia, diabetic ketoacidosis, propylene glycol, isoniazid, lactic
acidosis, ethylene glycol, and salicylates.
Mechanisms of Metabolic Acidosis
Four mechanisms result in a decrease in extracellular bicarbonate concentration and metabolic acidosis:
1. Dilutional acidosis. Rapid infusion of an alkali-free solution results in dilution of the bicarbonate
concentration.
2. Increased acid generation (e.g., lactic acidosis, ketoacidosis, salicylate poisoning).
3. Diminished renal acid excretion (e.g., renal failure or type I renal tubular acidosis [RTA]).
4. Decreased body bicarbonate content (e.g., severe diarrhea, fistula, type II RTA).
Table 11-18 Compensatory Mechanisms
361
No comments:
Post a Comment
اكتب تعليق حول الموضوع